DSpace Fukushima Medical University

福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.70 (2024) >

Please use this identifier to cite or link to this item: http://ir.fmu.ac.jp/dspace/handle/123456789/2443

Files in This Item:

File Description SizeFormat
FksmJMedSci_70_p119.pdf462.2 kBAdobe PDFDownload
Title: Current status of research on sarcopenia in post-treatment cancer survivors in Japan: A narrative review
Authors: Osaki, Keiichi
Fukushima, Takuya
Suzuki, Katsuyoshi
Kamimura, Akiho
Yanai, Saki
Morishita, Shinichiro
Affiliation: 理学療法学科
Source title: Fukushima Journal of Medical Science
Volume: 70
Issue: 3
Start page: 119
End page: 131
Issue Date: 2024
Abstract: Sarcopenia is prevalent among 11-25% of adult cancer survivors, depending on the cancer type, although the available data on post-treatment survivors in Japan are limited. If cancer patients develop cachexia, they may experience sustained weight loss as a result, ultimately leading to sarcopenia. Conversely, some patients experience post-treatment weight gain, resulting in sarcopenic obesity. Both sarcopenia and obesity elevate the risk of cardiovascular diseases and mortality; therefore, the importance of sarcopenia prevention and management is undeniable. The Guidelines for Exercise for Cancer Survivors recommend continued physical activity. Recent studies have reported the effectiveness of multimodal interventions, combining pharmacological, nutritional, and exercise approaches, necessitating multidisciplinary care for post-treatment sarcopenia. Innovative health interventions using mobile devices have also gained attention. However, studies on sarcopenia in post-treatment cancer survivors, especially those regarding exercise interventions, remain scarce in Japan, primarily due to limited insurance coverage for such post-treatment interventions and workforce challenges. It is clear that some cancer survivors have sarcopenia, which can lead to worse survival and secondary illness. While the benefits of exercise are clear, a comprehensive approach to sarcopenia is a further challenge for the future.
Publisher: The Fukushima Society of Medical Science
Publisher (Alternative foam): 福島医学会
language: eng
URI: http://ir.fmu.ac.jp/dspace/handle/123456789/2443
Full text URL: http://ir.fmu.ac.jp/dspace/bitstream/123456789/2443/1/FksmJMedSci_70_p119.pdf
ISSN: 0016-2590
2185-4610
DOI: 10.5387/fms.23-00019
PubMed ID: 38925958
Related Page: https://doi.org/10.5387/fms.23-00019
Rights: © 2024 The Fukushima Society of Medical Science. This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
Rights: https://creativecommons.org/licenses/by-nc-sa/4.0/
Appears in Collections:Vol.70 (2024)

Files in This Item:

File Description SizeFormat
FksmJMedSci_70_p119.pdf462.2 kBAdobe PDFDownload

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard